Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-23FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for budesonide from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2011-06-22FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for a generic combination tablet of fexofenadine HCl and pseudoephedrine HCl (ANDA 079043) to Dr. Re…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine [Phase 3]
Phase 3 trial update on levocetirizine for allergic rhinitis, featuring 3-D visualization of anti-obstructive effects; study status is compl…
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). [Phase 2]
Phase 2 trial evaluating the in vivo biological activity of Glycyphagus domesticus allergen extract using histamine equivalent units (HEP) a…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]
Phase 2 dose-finding study of Depigoid Birch in patients with allergic rhinitis, rhinoconjunctivitis, with or without asthma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial update reporting safety and tolerability of ToleroMune Grass in individuals with grass pollen–induced allergic rhinitis (rhino…
-
FDA approval · 2011-05-20FDA Approved: CHILDRENS ALLERGY — Original Application (Publix Super Markets Inc)
FDA approves an original ANDA for a pediatric cetirizine hydrochloride product marketed as CHILDRENS ALLERGY by Publix Super Markets Inc, ex…
-
CLINICAL_TRIALS research · 2011-05-16Clinical Trial Update: Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1 [Phase 1]
Phase 1 study evaluating immune response to hypoallergenic derivatives of Bet v 1, the major birch pollen allergen.
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber [Phase 1]
Phase 1 trial evaluating CAL-263 for allergic rhinitis completed; study assessed effects of CAL-263 in subjects exposed to allergen in an en…
-
FDA approval · 2011-04-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC, resulting in updated labeling for the p…
-
FDA approval · 2011-04-21FDA Approved: GOOD NEIGHBOR PHARMACY CHILDRENS LORATADINE — Supplemental Application (AmerisourceBergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Children's Loratadine (loratadine) by AmerisourceBergen.
-
FDA approval · 2011-04-13FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE ALLERGY RELIEF containing fexofenadine HCl, submitted by American Sales Company. Thi…
-
FDA approval · 2011-04-12FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for Dr. Reddy's Laboratories' generic fexofenadine hydrochloride, granting its approval as a gen…
-
FDA approval · 2011-03-07FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2011-02-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Dr.Reddy's laboratories Ltd.)
FDA approved Dr. Reddy's Laboratories' original application for levocetirizine dihydrochloride, a generic antihistamine. The approval covers…
-
FDA approval · 2011-02-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for levocetirizine dihydrochloride, a generic antihistamine.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Efficacy of SLITone in House Dust Mite Allergic Patients [Phase 2, Phase 3]
Phase 2/3 trial updates show efficacy results for SLITone in house dust mite–related allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation
A completed clinical trial evaluated how nasal nitric oxide measurements relate to atopy status in individuals with chronic nasal inflammati…
-
FDA approval · 2011-02-15FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Ohm Laboratories, enabling its cetirizine hydrochloride product to…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients
A completed clinical trial examined how asthma status and aeroallergen category influence psychological status in patients with allergic rhi…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children [NA]
The clinical trial evaluating cluster-specific immunotherapy in children with allergic rhinitis has completed. It reports distinct responses…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of fluticasone furoate nasal spray for two wee…
-
FDA approval · 2011-01-24FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for CHILDRENS ALLEGRA ALLERGY (fexofenadine hydrochloride) submitted by Chattem, Inc., typically to …
-
FDA approval · 2011-01-24FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, containing fexofenadine hydrochloride and pseudoephedrine hydr…
-
FDA approval · 2011-01-24FDA Approved: CHILDRENS ALLEGRA ALLERGY — Original Application (Chattem, Inc.)
FDA approves the pediatric formulation of Allegra Allergy (fexofenadine hydrochloride) for children under the original application, enabling…